Clinical trial
A Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid…
NCT00287261 · Universitaire Ziekenhuizen KU Leuven, Other · Completed
Key facts
| NCT number | NCT00287261 |
|---|---|
| Title | A Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM) |
| Official title | A Prospective Multicentre Phase II Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM) |
| Lead sponsor | Universitaire Ziekenhuizen KU Leuven, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myelofibrosis, Myeloid Metaplasia |
| Intervention type | Drug |
| Interventions | zoledronic acid |
| Enrollment | 17 |
| Start date | Feb 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Feb 6, 2006 |
| Last update posted | Dec 9, 2014 |
| Countries | Australia, Belgium, France, Germany, Israel, Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: